Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) June 9, 2025
CHEN Zhi-qiang, MI Xian-jun, LIU Jun, et al. Clinical Value of Peripheral Blood Circulating Tumor Cells Detection in Early Cervical Infiltrating Carcinoma Screening[J]. Journal of Sichuan University (Medical Sciences), 2019, 50(3): 415-419.
Citation: CHEN Zhi-qiang, MI Xian-jun, LIU Jun, et al. Clinical Value of Peripheral Blood Circulating Tumor Cells Detection in Early Cervical Infiltrating Carcinoma Screening[J]. Journal of Sichuan University (Medical Sciences), 2019, 50(3): 415-419.

Clinical Value of Peripheral Blood Circulating Tumor Cells Detection in Early Cervical Infiltrating Carcinoma Screening

More Information
  • Corresponding author:

    CHEN Ang, E-mail: 361782947@qq.com

  • Received Date: September 25, 2018
  • Revised Date: November 27, 2018
  • Available Online: October 28, 2019
  • Published Date: May 19, 2019
  •   Objective  To observe the difference of circulating tumor cells (CTC) in peripheral blood of patients with different degrees of cervical lesions, and to evaluate the effectiveness of CTC detection in screening early invasive cervical cancer.
      Methods  From December 2015 to October 2017, 63 cases of cervicitis, low-grade and high-grade intraepithelial lesions (LSIL, HSIL) and early invasive cervical cancer were confirmed by histopathological and clinical stages in Zhongshan Boai Hospital and Zhongshan Hospital Affiliated to Zhongshan University. The immunomagnetic bead negative enrichment technique combined with immunofluorescence was used. In situ hybridization (imFISH) was used to detect CTC in peripheral blood of patients. The positive rate and quantity of CTC in four groups were analyzed. The diagnostic efficacy of CTC in early invasive cervical cancer was evaluated based on the results of histopathological diagnosis and clinical staging.
      Results  ①The positive rates of CTC in cervicitis group, LSIL group, HSIL group and early invasive cervical cancer group were 0, 0, 19.05% and 84.13% respectively. The overall difference was statistically significant (χ2=504.00, P<0.05). The positive rate of CTC in early invasive cervical cancer group was higher than that in other groups (P<0.008 3). The positive rates of CTC in HSIL group were significantly different from those in LSIL group and cervicitis group (P<0.008 3). ②The average number (median) of CTC positive in cervicitis group, LSIL group, HSIL group and early invasive cervical cancer group was 0, 0, 1/4 mL, 3/4 mL, respectively. The average number of positive CTC in early invasive cervical cancer group was higher than that in other groups, and the difference was significant compared with other groups (P<0.008 3). The average number of CTC positive in HSIL group was significantly different from that in LSIL and cervicitis group (P<0.008 3). ③The sensitivity, specificity, coincidence rate, positive predictive value and negative predictive value of CTC positive results in the diagnosis of early invasive cervical cancer were 84.13%, 93.65%, 91.27%, 81.54% and 94.65%, respectively.
      Conclusion  CTC exists in patients with HSIL and early invasive cervical cancer. With the aggravation of cervical lesions, the positive rate and number of CTC test results increase. CTC detection in early invasive cervical cancer screening has a certain practical value in clinic.
  • [1]
    LEE YS, KIM YB, PARK SW, et al. Preservation of motion at the surgical level after minimally invasive posteriorcervical foraminotomy. J Korean Neurosurg Soc,2017,60(4): 433–440. DOI: 10.3340/jkns.2015.0909.006
    [2]
    NING N, ZHAN T, ZHANG Y, et a1. Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization. Clin Chim Aeta,2014,433: 69–75. DOI: 10.1016/j.cca.2014.02.019
    [3]
    郑迪凡, 陈海泉. 液体活检及其在非小细胞肺癌诊治中的研究进展. 中国肺癌杂志,2016,19(6): 394–398.
    [4]
    张凯莉, 高小妹, 钦伦秀, 等. 循环肿瘤细胞的生物学特性及意义. 复旦大学学报(医学版),2016,43(1): 94–98.
    [5]
    卢朝辉, 陈 杰. WHO女性生殖器官肿瘤学分类(第4版)解读. 中华病理学杂志,2014,43(10): 649–650. DOI: 10.3760/cma.j.issn.0529-5807.2014.10.001
    [6]
    FIGO Committee on Gynecologic Oncology. FIGO Staging forcarcinoma of the vulva, cervix, and corpus uteri. Int J Gynaecol Obstet,2014,125(2): 97–98. DOI: 10.1016/j.ijgo.2014.02.003
    [7]
    田晓坤, 李玉明, 胡宝光, 等. 胃癌患者外周血Cyttel循环肿瘤细胞检测及临床意义. 中华实验外科杂志,2017,34(2): 208–210. DOI: 10.3760/cma.j.issn.1001-9030.2017.02.010
    [8]
    苗 欣, 赵家义, 范银星, 等. 循环肿瘤细胞联合血清胃泌素释放前肽及神经元特异性烯醇化酶水平对 SCLC 化疗疗效的评估意义. 中国肿瘤生物治疗杂志,2017,24(4): 362–366.
    [9]
    CHEN H, CAO B, CHEN H, et a1. Combination of antibody-coated, physical-based microfluidic chip with wave-shaped arrays for isolating circulating tumor cells. Biomed Microdevices,2017,19(3): 66[2018-07-08]. DOI: 10.1007/s10544-017-0202-3
    [10]
    MASCALCHI M, MADDAU C, SALI L, et a1. Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions. J Cancer,2017,8(12): 2223–2230. DOI: 10.7150/jca.18418
    [11]
    李健斌, 耿翠芝, 闫 敏, 等. 循环肿瘤细胞采集仪捕集乳腺肿瘤患者循环上皮细胞的多中心临床观察. 中华医学杂志,2017,97(24): 1857–1861. DOI: 10.3760/cma.j.issn.0376-2491.2017.24.003
    [12]
    LIN X, FLEISHER M, ROSENBLUM M, et al. Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors. Neuro Oncol,2017,19(9): 1248–1254. DOI: 10.1093/neuonc/nox066
    [13]
    许 刚, 王 燕, 王承伟, 等. 食管癌放化疗中循环肿瘤细胞的变化及其临床意义. 中国肿瘤临床,2016,43(9): 381–384.
    [14]
    冯锦城, 杨 博, 代 辰, 等. 肝癌患者外周血中循环肿瘤细胞数量与肝移植后肿瘤早期复发的相关性研究. 中华器官移植杂志,2016,37(2): 76–80. DOI: 10.3760/cma.j.issn.0254-1785.2016.02.003
    [15]
    白东晓, 杨海军. 循环肿瘤细胞检测与结直肠癌复发转移的研究进展. 中国肿瘤临床,2017,44(3): 142–145. DOI: 10.3969/j.issn.1000-8179.2017.03.966
    [16]
    陈志强, 米贤军, 陈 昂, 等. 外周血循环肿瘤细胞检测在筛查卵巢上皮性癌中的应用. 中山大学学报(医学版),2018,39(6): 891–896.
    [17]
    LI Y, MA G, ZHAO P, et al. Improvement of sensitive and specific detection of circulating tumor cellsusing negative enrichment and immunostaining-FISH. Clin Chim Acta,2018,485: 95–102. DOI: 10.1016/j.cca.2018.06.034
    [18]
    TAKAKURA M, MATSUMOTO T, NAKAMURA M, et al. Detection of circulating tumor cells in cervical cancer using a conditionally replicative adenovirus targeting telomerase-positive cells. Cancer Sci,2018,109(1): 231–240. DOI: 10.1111/cas.2018.109.issue-1
    [19]
    FAN T, ZHAO Q, CHEN JJ, et a1. Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer. Gynecol Onco1,2009,112(1): 185–191. DOI: 10.1016/j.ygyno.2008.09.021
    [20]
    HE W, KULARATNE SA, KALLI KR, et a1. Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. IntJ Cancer,2008,123(8): 1968–1973. DOI: 10.1002/ijc.v123:8
    [21]
    CHEN L, BODE AM, DONG Z. Circulating tumor cells: moving biological insights into detection. Theranostics,2017,7(10): 2606–2619. DOI: 10.7150/thno.18588
    [22]
    LIU W, YIN B, WANG X, et a1. Circulating tumor cells in prostate cancer: precision diagnosis and therapy. Oncol Lett,2017,14(2): 1223–1232. DOI: 10.3892/ol.2017.6332
    [23]
    黄宝英, 周伦顺, 富显果, 等. HPV E6/E7mRNA检测对子宫颈癌筛查意义的初步评价. 中华肿瘤防治杂志,2017,20(14): 1061–1064.
    [24]
    LIU Y, ZHANG L, ZHAO G, et a1. The clinical research of Thinprep Cytology Test (TCT) combined with HPV-DNA detection in screening cervical cancer. Cell Mol Biol (Noisy-le-grand),2017,63(2): 92–95. DOI: 10.14715/cmb/2017.63.2.14

Catalog

    Article views (1964) PDF downloads (40) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return